Skip to main content
Heidi Cuthbert CEO Grafa
Heidi Cuthbert

Heidi Cuthbert

GrafaCEO & Founder

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.

Articles by Heidi Cuthbert

Grafa
Health

Precision BioSciences gains FDA fast track status for Duchenne gene editor

Precision BioSciences (NASDAQ:DTIL) shares are in focus after the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD, an investigational in vivo gene editing therapy designed to treat Duchenne muscular dystrophy (DMD).

Read more: Precision BioSciences gains FDA fast track status for Duchenne gene editor
Grafa
Health

Corbus Pharmaceuticals tops estimates as obesity and cancer data take center stage

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) reported a fourth-quarter loss that was narrower than analysts anticipated, bolstered by a significant cash injection and clinical progress in its high-priority obesity and oncology programs.

Read more: Corbus Pharmaceuticals tops estimates as obesity and cancer data take center stage
Grafa
Health

Pfizer's Tilrekimig hits primary endpoint in atopic dermatitis Phase 2 trial

Pfizer announced positive topline results for its investigational trispecific antibody, tilrekimig, which demonstrated significant skin clearance in adults with moderate to severe eczema and paved the way for a pivotal Phase 3 study later this year.

Read more: Pfizer's Tilrekimig hits primary endpoint in atopic dermatitis Phase 2 trial